Renalytix plc SEC filings RENXF
Renalytix plc has 233 filings in SEC EDGAR's recent list, going back to May 15, 2020. Its latest annual report, Form 10-K, was filed on Sep 30, 2024 for the period ended Jun 30, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 19, 2024, covering the quarter ended Sep 30, 2024. The most recent current report (Form 8-K) was filed on Jan 16, 2025 (regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 23, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 30, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 30, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2025 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 7, 2024 | — |
| 4 | Insider transaction | Nov 5, 2024 | Nov 1, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 5, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 2, 2024 | — |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 3 | Initial insider ownership | Jun 5, 2024 | May 27, 2024 |
| 4 | Insider transaction | Apr 26, 2024 | Apr 24, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Apr 26, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Apr 4, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Mar 21, 2024 | — |
| 4 | Insider transaction | Nov 22, 2023 | Nov 20, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 20, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 20, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 20, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 20, 2023 |
| 3 | Initial insider ownership | Sep 12, 2023 | Sep 1, 2023 |
| 4 | Insider transaction | Jul 11, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 6, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 6, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 6, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 6, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 6, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 6, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| SC 13D | Ownership over 5% (active) | Feb 17, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13D | Ownership over 5% (active) | Feb 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | May 27, 2022 | — |
| SC 13G | Ownership over 5% (passive) | May 27, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 11, 2022 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- RNLXY (OTC), RENXF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- United Kingdom
- Headquarters
- London
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1811115
- Former names
- Renalytix AI plc (until Jun 25, 2021)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.